Solstice Neurosciences is a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. Solsticeâ€™s first product named MyoblocÂ® (rimabotulinumtoxinB) Injection in the...
Total money raised: $93M
701 Gateway Boulevard
South San Francisco
Solstice Neurosciences raised $85M in a Series B round from Highland Capital Partners, Thomas, McNerney & Partners, Investor Growth Capital, Morgan Stanley Venture Partners, and Oxford Bioscience Partners
Solstice Neurosciences raised $8M in unattributed round from Morgan Stanley Venture Partners, Thomas, McNerney & Partners, Oxford Bioscience Partners, and Investor Growth Capital